Skip to main content
Hepato-gastroenterology unit on Muck Rack

Hepato-gastroenterology unit

As seen in: Wiley Online Library, European Journal of Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hepato-gastroenterology

Contact Hepato-gastroenterology, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

AdipoRon enhances healthspan in middle‐aged obese mice: striking alleviation of myosteatosis and muscle degenerative markers

|
By Camille M. Selvais, Maxime Nachit, Hepato-gastroenterology unit, Romain Versele
| Wiley Online Library Verified
Acknowledgements This work was supported by grants from UCL University (Research project FSR 2017), Société Francophone du Diabète/Roche Diabetes Care 2020 and Fund for Scientific Research—FNRS (Research Credit 35275437, 2019). M. A. -S. is Chargé de Recherches and C. M. S. has received a fellowship from the FRIA. M. A. D. -L. d. C. received a fellowship from the Wallonie-Bruxelles International Excellence Program.
Open in Who Shared Issue with article?

The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms

|
By Ivan Borbath, Hepato-gastroenterology unit, Cliniques Universitaires Saint-Luc, Rocio Garcia-Carbonero
| European Journal of Cancer Verified
Background Neuroendocrine neoplasms (NENs) are rare tumours with variable clinical behaviour. Their natural history is ideally best approached in large, multicentre and multinational registries with long-term patients’ follow-up. The European Neuroendocrine Tumour Society registry aims to obtain information regarding NEN outcomes and prognostic factors in a European frame.
Open in Who Shared Issue with article?

PLOS ONE: Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion

|
By CHU Grenoble, Juliana Bruder Costa, Hepato-gastroenterology unit, Tania Dufeu-Duchesne
| PLOS
Pegylated interferon α-2a (Peg-IFN-α) represents a therapeutic alternative to the prolonged use of nucleos(t)ide analog (NA) in chronic hepatitis B (CHB) infection. The mechanisms leading to a positive clinical outcome remain unclear. As immune responses are critical for virus control, we investigated the effects of Peg-IFN-α on both innate and adaptive immunity, and related it to the clinical evolution.
Open in Who Shared Issue with article?
See all 3 articles